"Cardiac Surgery is the first request from a lot of poor countries." -Daniel Sidi, Nov.3rd 2008, SAHA meeting.
bUrDEN OF DIsEAsE
The "big three" communicable diseases -malaria, HIV and tuberculosis -dominate, and the "epidemiological transition" toward non-communicable disease that is reportedly beginning in the adult population (9) is not yet seen for children. Reasons for this relate to persistent poverty and malnutrition, lack of basic sanitation and clean water, and poor access to healthcare. (10) Cardiac diseases simply add to this enormous health burden for the average child.
Acquired heart disease
Acquired heart disease in Africa is predominantly rheumatic heart disease (RHD), consequent upon recurrent attacks of acute rheumatic fever (ARF). A single attack of ARF may progress to RHD, but most RHD results from the cumulative damage of repeated attacks. (11, 12, 13, 14) Over the past century the incidence of ARF and RHD has declined steeply in developed countries; the initial and most rapid decline was before the antibiotic era, due mainly to improving socioeconomic conditions. (15, 16, 17) RHD is today rarely seen in developed nations; (18, 19, 20) already by the 1980s it was thought to be virtually eradicated. (20) Yet RHD remains the most common form of cardiac disease in children and young adults in Africa and a major public health concern. (16) It is the most preventable form of cardiac disease, though difficult to treat effectively without surgery, (13) which is expensive, generally unavailable, and involves high-cost prostheses; (20) it is also only a partial solution, especially in a [95] [96] [97] [98] [99] FIGUrE 1: Age pyramid: south Africa the South African age pyramid illustrates the classic prominent "youth bulge" of developing nations. the bulk of the population is under 25 years old, the age group most affected by the twin epidemics of acquired (rheumatic) and congenital heart disease. resource-poor setting where adequate coagulation control is unlikely. (21, 22, 23) While there is no reliable data on the incidence of ARF in Africa, (24) the reported incidence of RHD varies widely. In developed countries it is less than 0.5 per 1 000 population, (25) but is high in poor nations, for example 78 per 1 000 in Samoa. (26) In Africa, early reports based on auscultatory screening of school-going children gave incidences from 2.7 to 20 per 1 000 population. (16, 27, 28, 29) Recently Marijon et al reported an incidence in Mozambique of 30.4 per 1 000 using echo-based screening of schoolchildren, (30) probably a better estimate. Because of the difficulty in obtaining data, it is possible that the true incidence in many areas is even higher. Using echocardiography, Bonhoeffer reported an incidence of mitral regurgitation in rural Kenya of 62 per 1 000. (31) One third to half of all cardiac hospital admissions in developing countries are due to RHD, with an average length of stay of 3 to 4
weeks. (32, 33) The typical age affected is 5 to 18 years. (32, 33, 34) There is widespread evidence that in developing nations RHD occurs at a younger age than in developed countries, and also progresses more rapidly, though this may reflect more frequent attacks of ARF, (33, 35, 36, 37, 38, 39, 40, 41) as without intervention, the sequence of events is predictable: after the initial infection with Lancefield group A β-haemolytic streptococci 3% of patients develop ARF approximately 19 days later. (42) At reinfection, the incidence increases sharply to more than 75% of patients. (43, 44, 45) During ARF, carditis is present in 40-80% of patients; of those with carditis, 90% will develop chronic progressive RHD. (46, 47, 48, 49) ( Figure 2 .)
The initial carditis is characterised by fibrinoid collagen degeneration followed by a proliferative phase 1-6 months later. At that stage, the pathology is defined by annular dilatation, chordal elongation and anterior leaflet prolapse. (50) Thus the hallmark of acute rheumatic carditis is the pan-systolic murmur of mitral regurgitation (MR). If heart failure occurs in the wake of acute carditis with MR leading to LV dilatation, only surgical correction can lead to improvement. (50) The severity of LV dysfunction correlates more with the extent of the valvulitis than with the myocardial injury, although myocarditis co-exists in 30%
to 70% of cases. (51) Eighty to 90% of those with severe MR during an ARF attack will develop clinically significant RHD. Of 9-year old children surviving ARF, 20% will be dead by the age of 15 years (52) and more than 70% by 25 years. (53, 8) The majority of the latter group will have mitral and aortic regurgitation at death. Due to
ChildrEn'S hEArt diSEASE FIGUrE 2: An outline of the process from streptococcal infection to rheumatic heart disease. Millions are quietly dying from rhd in Africa, with virtually no access to treatment and very little done to prevent acute rheumatic fever. (53, 54) its incidence increasing with age. (37) The economic effects of RHD on communities are well described. (53, 55, 56) Without access to surgery, the costs of repeated hospitalisation are significant. There are also intangible costs from premature disability and death, endocarditis and stroke, and loss of schooling and training. (25, 35, 55, 57, 58, 59, 60, 61) Two-thirds of children with RHD leave school early. (62) RHD indirectly affects national productivity, the young adults it affects being the most productive segment of the population. (60, 62, 63) RHD is also responsible for 10% of maternal deaths, (64, 65) and is the main predisposing factor for infective endocarditis in Africa, (66, 67, 68, 69) occurring at a mean age of 27 years. (70) Congenital heart disease
Incidences of "significant" congenital heart disease (CHD) (i.e.
what will require expert cardiological care at some stage) are generally reported at about 1% of live births or slightly less, (4, 71, 72, 73) with eight common types of lesions making up 85% of all clinically significant CHD (ventricular septal defect, atrial septal defect, patent ductus arteriosus, pulmonic stenosis, tetralogy of Fallot, coarctation of the aorta, aortic stenosis, atrioventricular septal defect.) (72) Most reliable studies indicate that, with only minor variations, the incidence is constant worldwide, across geographic and ethnic backgrounds, and in spite of variations in socio-economic conditions. (4, 72, 74) Thus it is valid to extrapolate these estimates to developing nations.
There are factors that may in fact suggest a higher estimate. For example, CHD may be undetected in infancy, not being included in studies that tend to focus on infancy; (74) one in four cases of CHD in the UK is diagnosed later in childhood. (75) In the USA at least 10% of patients with CHD first present in adulthood. (76) Without appropriate treatment, about half of those born with significant CHD will die in infancy or early childhood, a third of them within the first month of life. (77) Most who survive longer will become debilitated by the cardiac defect. (7, 77) Thus, of the approximately 50 million live babies born every year in Africa, (5, 6) as many as 500 000 will have significant CHD that will require expert cardiological care; about half will die within a few years of birth. There is also a large pool of older children and adults with CHD that survived the early years who are debilitated by the disease. This is while paediatric cardiac medicine has advanced to the point that outcomes for children with heart lesions is in most cases excellent.
The exact cause of CHD is not known in most cases, though there are known contributory factors. These include genetic defects and chromosomal abnormalities, maternal intrauterine viral infections such as rubella, certain medications taken in early pregnancy, consanguineous marriages, etc.
(78)
PrEVENtION
Nowhere is the absurdity of a lack of prevention of RHD, in the face of heroic efforts to treat it, better described than in McLaren's 1994 statement likening it to "attempting to mop up the water on the floor while leaving the faucet open." (79) On purely economic grounds, it is clear that prevention of RHD is an urgent need. (8, 33) ARF can be prevented through timely antibiotic treatment for streptococcal sore throat (primary prophylaxis); progression to RHD through recurrent attacks can be prevented by ongoing antibiotic therapy (secondary prophylaxis). (80) Secondary prophylaxis appears to be a most cost-effective strategy for Africa. (33, 80) It may be unrealistic to expect to see advanced paediatric cardiac care in the near future in poor countries, but it is possible that prevention of ARF/RHD could be incorporated into most basic health systems, as the Indian example shows. (81) A welcome development in this regard was the adoption, at the these exercises are at best not cost-effective, and at worst a waste of donor money that could have been used for something more sustainable. (23, 84, 85) NGOs have generally now shifted focus towards building longterm partnerships with recipient sites with a vision to eventually develop autonomous local services. There is a growing consensus about the need to work together to build regional centres which themselves can become a resource to surrounding areas and countries through satellite outreaches. (84, 85, 86, 87) Such regional "surgical hubs" could form training and resource bases for surrounding countries, with international aid coordinated at one centre rather than being diluted through multiple small efforts. is directed toward first-world needs for both pharmaceuticals and technology. (95) Other approaches that were commonplace in the early days of cardiac surgery could be appropriate for developing nations unable to afford high tech developments. For example, closed mitral valvotomy using a Logan-Tubbs dilator, which cheaply and effectively saved thousands of lives from 1954 into the 1980s before expensive catheter-based alternatives came into vogue. (96, 97, 98) Many cardiac centres still have the old dilators, though the skills required for the procedure are almost lost.
ObstAcLEs
If the communicable disease burden amongst children in subSaharan Africa should diminish, cardiac diseases will be highlighted as the major non-communicable problem. (10) However, more important than individual diseases are the "prior questions," the issues that drive the problem. If these questions were resolved, the burden of disease would shift toward non-communicable disease, the so-called "epidemiological transition" that is hoped for. (9) The "prior questions" that block the shift include: socioeconomic issues of malnutrition and poverty, complicated by recurrent drought and famine; the increasing economic divide and the economic policies of wealthy nations, with globalisation and marginalisation; poor health infrastructure, referral systems, transport infrastructures; political priorities focused on issues other than health; civil unrest and war; the "brain drain", a virtual evacuation of skills; and the debilitating effects of foreign aid and foreign debt.
In many countries more money is spent on servicing debt than on health and education combined. disease is part of the context of goal number 4, to "reduce by two thirds the mortality rate among children under five." It is most unlikely that this will be achieved by 2015, (102, 103) but any progress made will make paediatric heart disease increasingly important as a cause of morbidity and mortality. Progress would also free up health resources.
Alarmingly, the under-5 mortality in South Africa has actually increased, (104) even though there has been a small decrease in Africa as a whole over the first 8 years of the MDG process. (104) This context of extreme poverty and unmanageable burden of disease must be part of our consideration in seeking to develop cardiac care. However, if we can benefit children with cardiac disease using funds that would not otherwise be made available for the broader problems, then the overall healthcare infrastructure would surely benefit.
sOME sUGGEstED WAYs FOrWArD
The task seems overwhelming, yet many organisations and individuals have taken up the challenge, and some progress has been made, albeit slow. Major reasons for slow progress are lack of funding and lack of cooperation (or lack of interest?) at local government levels to enable sustainability of a cardiac programme.
Health expenditure is a large part of the GDP in developed nations, but only a small fraction in African countries, (84, 105) keeping most tertiary services out of reach. Many strategies have been tried to improve the situation, but the main question is: How can we accelerate progress? Here are some suggestions.
Work together
Those of us currently involved in paediatric cardiac care in Africa need to work together, coordinating our efforts to become as cost-efficient and appropriate as possible, seeking to be a pressure group that can attract attention and action from local govern- Interaction and mutual support could become a continent-wide network to share ideas and frustrations and help build a community that will promote, build, and sustain cardiac care. (see Figure 3 .)
Build local infrastructure through teams
There is no point in training a surgeon who has no local infrastructure in which to work, yet this has been done many times, usually because the individual seeks out the training for him-or herself.
There are in Africa trained cardiologists with no surgical support, and vice versa. A full support team is required for a cardiac service. (73) We know of a group who could not operate for lack of a perfusionist, so we trained one of the surgeons in perfusion technology, a relatively quick process. Equipment is vital too. We are trying to source a bypass pump for another group who cannot operate for lack of one.
The goal of training must be a complete local team that can sustain a programme. This requires coordination; training centres must liaise with administrations, preferably university centres where peer pressure and academic values will form strategies, and not with individuals. Training need not all be in one centre or even in one country, as long as the team strategy is in place.
Support from a local authority or university has proven important for success, as are strategic funding partners interested in building
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Paid fellowships in South Africa for Africans could help us if we are, as some say, training too many surgeons. Funding is commonly an issue for Africans seeking training.
An example of coordinated training is the Namibian Heart Project:
we are training personnel in our unit at all levels, aimed at forming an autonomous team in Windhoek, whilst some key persons of the team are training at other units. A coordinated approach ensures there are no gaps to prevent the service being initiated and sustained.
Training partnerships with large units in developed countries are of benefit to both sides; visiting first-world personnel are exposed to pathology they seldom see.
Prevention
As has been mentioned, secondary prophylaxis of rheumatic fever is an important strategy for RHD. (8, 24, 33, 106) Many notable successes have been reported through prevention programmes with decreased prevalence, hospital morbidity and mortality; for example in Cuba, Costa Rica, Egypt, Martinique and Guadeloupe, (12, 16, 60, 61, 107, 108, 109, 110, 111, 112, 113) and the development of the A.S.A.P. proposal holds similar promise in this regard for Africa. (82) Yellow dots indicate functional cardiac surgical units outside of South Africa, some of which operate on some children.
African countries that have consulted with the UCT cardiothoracic unit seeking collaboration on paediatric cardiac services within the past year.
there is perhaps a place to begin with a simplified approach to PASCAR could again be a useful facilitator.
Coordination of personnel data on a database of trained experts and even volunteers may be another useful tool in building local teams.
Appropriate research
There is a great deal of inappropriate and even unethical research going on in Africa, much of it driven by the needs of the developed world. There are university medical complexes without basic laboratory facilities who have an MRI scanner, because a foreign foundation needed it for a particular project. The medical community of Africa needs to take a stand on appropriateness of research and expenditure.
Simple documentation of epidemiology would be an suitable start as a route to pressuring funders. There is, for example, no good data on the incidence of acute rheumatic fever in Africa, and at one time it was thought not to be a significant problem. (24) Plugging the "brain drain"
The lack of appropriate remuneration is commonly considered the main reason for loss of skills from Africa, but there are many other important causes; lack of team support to enable cardiac surgery, lack of equipment, political uncertainty, poor career prospects, and pressure from the disease burden are some of them. (2, 4) Active recruitment by developed nations also contributes; the best trainees from Africa are lured away. South Africa, even our own institution, is part of this problem.
An example of the scope of the dilemma: the Malawi Medical
School in Blantyre has funded 21 doctors for specialist paediatric training in developed nations over 10 years; 18 completed the training, but only one has returned to Malawi, in spite of various incentive programs. (116) ChildrEn'S hEArt diSEASE Support groups need to address this. Institutions and governments need to be taken to task for the way they use personnel from developing nations to make up their own shortfalls.
recommendations for international organisations
Apart from all the above discussion, international aid groups should also be encouraged to:
Coordinate efforts between organisations and with local African efforts.
Undertake advocacy for increased international assistance through government policies.
Engage African governments on issues of health policy.
Learn from one another; some NGOs have gone through a long learning curve and have much to teach on how to help Africa.
cONcLUsION
"Every observer of human misery among the poor reports that disease plays the leading role. " -Irving Fisher (116) There is a hidden epidemic of dying and disabled children in Africa.
There is much that the world's cardiac practitioners could do to address the problem, and there seems to be a growing willingness in the cardiac community to do just that, but little coordination or agreement about strategy. It will take a lot of time and effort, and no small amount of sacrifice, to make any significant change.
As cardiac practitioners in Africa, we need to take a lead in directing and advising, in open collaboration with one another and with our colleagues throughout the continent and internationally. Children have a particularly raw deal with heart disease; the major ordeal of surgery has to be endured before they can even begin on the journey of life, and yet in our continent very few even have this option.
